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Background: Critical to sustaining progress in malaria control is comprehensive surveillance to identify outbreaks
and prevent resurgence. Serologic responses to Plasmodium falciparum antigens can serve as a marker of recent
transmission and serosurveillance may be feasible on a large scale.
Methods: Satellite images were used to construct a sampling frame for the random selection of households
enrolled in prospective longitudinal and cross-sectional surveys in two study areas in Southern Province, Zambia,
one in 2007 and the other in 2008 and 2009. Blood was collected and stored as dried spots from participating
household members. A malaria rapid diagnostic test (RDT) was used to diagnose malaria. An enzyme immunoassay
(EIA) was used to detect IgG antibodies to asexual stage P. falciparum whole parasite lysate using serum eluted
from dried blood spots. The expected mean annual increase in optical density (OD) value for individuals with a
documented prior history of recent malaria was determined using mixed models. SatScan was used to determine
the spatial clustering of households with individuals with serological evidence of recent malaria, and these
households were plotted on a malaria risk map.
Results: RDT positivity differed markedly between the study areas and years: 28% of participants for whom
serologic data were available were RDT positive in the 2007 study area, compared to 8.1% and 1.4% in the 2008
and 2009 study area, respectively. Baseline antibody levels were measured in 234 participants between April and
July 2007, 435 participants between February and December 2008, and 855 participants between January and
December 2009. As expected, the proportion of seropositive individuals increased with age in each year. In a subset
of participants followed longitudinally, RDT positivity at the prior visit was positively correlated with an increase in
EIA OD values after adjusting for age in 2007 (0.261, p = 0.003) and in 2008 (0.116, p = 0.03). RDT positivity at the
concurrent visit also was associated with an increase in EIA OD value in 2007 (mean increase 0.177, p = 0.002) but
not in 2008 (−0.063, p =0.50). Households comprised of individuals with serologic evidence of recent malaria
overlapped areas of high malaria risk for serologic data from 2009, when parasite prevalence was lowest.
Conclusions: Serological surveys to whole asexual P. falciparum antigens using blood collected as dried blood
spots can be used to detect temporal and spatial patterns of malaria transmission in a region of declining malaria
burden, and have the potential to identify focal areas of recent transmission.* Correspondence: tkobayas@jhsph.edu
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Increased funding for malaria control and elimination
has led to implementation of comprehensive control
programmes and concomitant reductions in the burden
of malaria in many parts of sub-Saharan Africa [1,2].
Zambia has been a model country for malaria control
within sub-Saharan Africa and has achieved a significant
decline in the burden of malaria [3,4]. Zambia’s national
malaria control programme includes provision of
artemisinin-based combination therapy, distribution of
insecticide-treated nets, indoor residual spraying in
urban and peri-urban areas, and intermittent preventive
treatment of pregnant women [3,5]. By 2008, the preva-
lence of parasitaemia and severe anaemia in children
between six and 59 months of age decreased by 53% and
68%, respectively, compared with levels in 2006 [3]. In
April 2009, the World Health Organization announced
that Zambia reached the 2010 Roll Back Malaria target
of greater than 50% reduction in malaria mortality
compared to levels in 2000 [6].
Despite this impressive achievement, the incidence of
malaria increased in five of nine provinces of Zambia in
2010 [4,7]. The greatest resurgence occurred in Eastern
and Luapula Provinces, where the number of reported
cases of malaria doubled from levels in 2008 [4]. Such
trends highlight the challenge of sustaining effective
malaria control. Critical to such control is effective sur-
veillance to identify outbreaks, target control efforts and
prevent resurgence. Serologic responses to Plasmodium
falciparum can serve as a proxy measure of malaria
transmission [8-13] and may be a useful tool for
enhanced surveillance in the pre-elimination phase of
malaria control. Measurement of antibodies to single
parasite antigens such as MSP-119 and AMA-1 identified
infection within the previous four months among chil-
dren younger than six years of age in The Gambia [14].
Serologic surveillance may be feasible on a large scale
using blood collected on filter paper [15] or oral fluid
samples [16,17]. IgG antibody levels to whole, asexual P.
falciparum lysate were measured by enzyme immuno-
assay in two community-based cohorts in southern
Zambia to assess the utility of serological surveys to
identify temporal and spatial patterns of recent malaria




The study was conducted in two sites within the catch-
ment area of Macha Hospital in Choma District, Southern
Province, Zambia between April 2007 and December 2009.
Macha Hospital is located approximately 70 km from the
nearest town of Choma on a plateau at an altitude of
approximately 1,100 meters above sea level and in a habitatcharacterized as Miombo woodland. A single rainy season,
lasting from approximately December through March, is
followed by a cool, dry season from April to July, and a
hot, dry season from August to November. The catchment
area is populated by traditional villagers living in small,
scattered homesteads. Anopheles arabiensis is the primary
vector responsible for malaria transmission [18], which
peaks during the rainy season. The study site in 2007 con-
sisted of a 525 km2 region to the east of Macha Hospital
(Figure 1). In 2008 and 2009, the study site was shifted to a
575 km2 area west of the 2007 study site (Figure 1).
The Southern Province of Zambia historically had hyper-
endemic transmission of P. falciparum [19]. More recently,
the entomological inoculation rate for An. arabiensis was
estimated to range from 1.6 to 18.3 infective bites per
person per season [18]. Zambia introduced artemether-
lumefantrine as first-line anti-malarial therapy in 2002,
which reached the Macha Hospital catchment areas in
2004, and insecticide-treated bed nets (ITNs) were widely
distributed in Southern Province, Zambia in 2007.
Widespread indoor residual spraying has not been
conducted in the study areas.
Study design and methods
Satellite images were used to construct a sampling frame
for the random selection of households enrolled in
prospective longitudinal and cross-sectional surveys [20].
The sampling frame for the random selection of house-
holds was constructed from a Quickbird™ satellite image
obtained from DigitalGlobe Services, Inc. (Denver,
Colorado). The image was imported into ArcGIS 9.2
(Redlands, CA) and locations of households were identi-
fied and enumerated manually. Structures of appropriate
size and shape were identified as potential residences.
Household locations of cases and controls were col-
lected in the Universal Transverse Mercator, Zone 35
south coordinate system. Selected households were allo-
cated to one of two study cohorts: longitudinal and cross-
sectional. Households in the longitudinal cohort were
surveyed repeatedly approximately every other month
and households in the cross-sectional cohort were
surveyed once.
All individuals residing within a selected household
were eligible to participate. After obtaining permission
from the head of household and individual written
informed consent, a questionnaire was administered to
each participant older than 16 years of age residing within
the household and to parents or guardians of those
younger than 16 years of age. Data collected included
demographic information, history of recent malaria and
anti-malarial treatment, knowledge of malaria transmission
and prevention, and the use of ITNs.
A blood sample was collected by finger prick for a rapid
diagnostic test (RDT) for malaria and preparation of dried
Figure 1 Location of study households in the 2007 and 2008–2009 study areas in Choma District, Southern Province, Zambia.
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(Whatman, Protein Saver card 903, Piscateway, New
Jersey), dried overnight and stored individually with desic-
cant in a sealed plastic bag at −20°C. DBS collected in
2007 were stored with desiccant at room temperature and
DBS collected from February to September in 2008
were initially stored at room temperature but subse-
quently stored at −20°C. All samples collected after
September 2008 were stored at −20°C.
A RDT (ICT Diagnostics, Cape Town, South Africa)
was used to detect P. falciparum histidine-rich protein 2.
This RDT was reported to detect 82% of test samples with
P. falciparum at a concentration of 200 parasites/μL and
98% of test samples with a concentration of 2000
parasites/μL, with false positives in 0.6% of negative sam-
ples [21]. Individuals who were RDT positive were offered
treatment with artemether-lumefantrine (CoartemW).
The study was approved by the University of Zambia
Research Ethics Committee and the Institutional Review
Board at the Johns Hopkins Bloomberg School of Public
Health.Laboratory methods
Antibodies to whole asexual parasite (NF54) lysate were
measured by enzyme immunoassay using serum extracted
from DBS. A circle of 7 mm (corresponding to approxi-
mately 10 μL blood volume) in diameter was punched out
of the DBS and half of the circle (approximately 5 μL
blood volume, therefore 2.5 μL of serum) was used to
extract serum. The half circle was soaked in 500 μL (1:200
dilution of serum) 5% skim milk in PBS containing 0.05%
Tween 20 (PBST) for 1 hour at room temperature. Immu-
lon 2HB flat-bottomed 96-well plates (Thermo, Rochester,
New York) were coated with 1 μg/mL of whole P. falcip-
arum asexual stage lysate diluted in PBS and incubated
overnight at 4°C. Plates were washed with PBST three
times, blocked with 5% skim milk in PBS for 1 hour at 37°
C, and washed again with PBST four times. Eluted sam-
ples were plated in triplicate and incubated for 1 hour at
37°C. Negative control serum (pooled serum from adults
who had never been exposed to malaria) and positive con-
trol serum (serum from adults who resided in malaria en-
demic areas of Zimbabwe or Zambia) were diluted 1:200
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plate. The plates were subsequently washed with PBST
four times and incubated for one hour at 37°C with
peroxidase-labeled goat anti-human IgG (KPL, Inc.,
Gaithersburg, Maryland). Following four washes, the
plates were incubated for 15 minutes with 100 μL of
ABTS solution (KPL). Absorbance was measured at 405
nm and IgG levels were expressed as the optical density.
A threshold optical density (OD) value of 0.57 was
established to distinguish seronegative from seropositive
individuals based on the mean OD value plus three
standard deviations from filter paper spotted with serum
from ten individuals never exposed to malaria. Indivi-
duals with OD values above this threshold were defined
as seropositive. Results were included only if the
standard deviation of the triplicate values was within
20% of the mean OD value. The mean standard
deviation for the triplicate values was 0.020 in 2008
and 0.026 in 2009.
Statistical methods for the longitudinal analysis
Associations between RDT positivity and antibody levels
to P. falciparum antigens, expressed as OD values and
adjusted for age, were analyzed using data from partici-
pants enrolled in the longitudinal cohort. Malaria infec-
tion was defined in two ways: 1) a positive RDT result
on the day of the study visit was defined as concurrent
malaria; and 2) a positive RDT result at any previous
study visit was defined as prior malaria. The change in
antibody level over the one year study period was
expressed as the mean difference in OD values between
study visits. To account for within-subject correlation, a
linear regression model was fitted adjusting for within
subject correlation, with random intercept and robust
standard errors.
Statistical methods for the spatial analysis
Using the coefficient for the change in the OD value in
individuals with a prior documented history of recent
malaria, participants enrolled in the longitudinal cohort
in 2008 and 2009 were categorized as either a case or
control. A case was defined as an individual whose





Number of participants 90 144
Median age in years (range) 12.8 (0.50-83) 12.1 (0.21-86) 1
Male (%) 44 (49) 63 (44)
RDT positive (%) 29 (32.2) 37 (25.7)at the end of the study year exceeded the coefficient
from the linear model, and thus represented someone
with a greater than expected increase in OD value and
serological evidence of recent exposure to P. falciparum.
A control was defined as an individual whose change in
OD value from the first to the last study visit at the end
of the study year did not exceed the coefficient from the
linear model. Spatial clustering of cases was analyzed
with SatScan™ software (version 9.0) using the Kulldof
spatial statistic [22] and a Bernoulli probability model.
Coordinates were specified using a Cartesian coordinate
system and the maximum spatial cluster size was set at
50% of the population at risk. To detect clusters, SatScan
generated circular windows of different sizes. The circu-
lar window shape is the most commonly used shape
[23,24] and represents the most compact area. The num-
ber of cases in each window was compared to the
expected number of cases based on the total population
size and the total number of cases. The likelihood func-
tion was maximized over all scanned windows and the
window with the maximum likelihood function was the
cluster least likely to arise by chance. The p-value was
obtained through Monte Carlo hypothesis testing with
999 simulations.
Results
Baseline characteristics of participants
Antibody levels to P. falciparum antigens were measured
in 234 participants between April and July 2007 (cross-
sectional cohort = 90, longitudinal cohort = 144), 435
participants between February and December 2008
(cross-sectional cohort = 317, longitudinal cohort = 118),
and 855 participants between January and December 2009
(cross-sectional cohort = 675, longitudinal cohort = 180).
Most participants enrolled in the longitudinal cohort
in 2008 continued to be followed in 2009, although
three longitudinal households were replaced and six
new households were added in 2009. The median age
of the study participants was 12.2 years (interquartile
range [IQR]: 5.08, 29.9) in 2007, 14.2 years (IQR:
6.34, 34.2) in 2008, and 14.0 years (IQR: 6.34, 32.1)
in 2009). Slightly less than half of the participants






317 118 675 180
4.2 (0.25-84) 14.3 (0.39-78) 14.0 (0.07-85) 13.0 (0.23-79)
149 (47) 58 (49) 322 (48) 85 (47)
31 (9.78) 4 (3.39) 10 (1.48) 2 (1.11)
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year: 24% of the baseline population (cross-sectional
cohort plus the first visit of longitudinal cohort) was
RDT positive in the eastern area in 2007, compared
to 8.1% and 1.4% in the western area in 2008 and
2009, respectively.
Seropositivity increased with age
IgG antibody levels to P. falciparum were measured in
the baseline study population consisting of participants
in the cross-sectional cohort and the first visit of the
longitudinal cohort. In each year, the proportion of
seropositive individuals increased with age (Figure 2).Figure 2 IgG antibody levels to P. falciparum whole antigen expresse
A Lowess curve was fit to the data. The straight line indicates the threshold
standard deviations.Consistent with the differences in parasite prevalence,
the proportion of seropositive children younger than
five years of age was lower in the 2008 and 2009
study areas than in the 2007 study area (34% in 2007,
11% in 2008 and 12% in 2009).
RDT positivity was positively correlated with higher
serologic responses
The effect of documented malaria during the study
period on antibody levels to P. falciparum antigens was
assessed among participants in the longitudinal cohort.
In 2007, 114 individuals enrolled in the longitudinal
cohort had at least two study visits. Of these, 47 had atd as optical density values by age: A. 2007, B. 2008 and C. 2009.
OD value established using the mean OD value plus three
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with two RDT positive results and two participants
with three RDT positive results. To test the effect of
having multiple RDT positive results during prior
visits, the OD values at the end of 2007 study year
among participants with a single positive RDT (mean
OD = 1.29) was compared to participants with
two or three RDT positive results (mean OD = 1.09;
p = 0.66). As there was no statistically significant dif-
ference in mean EIA OD between individuals with a
single or multiple RDT positive results, RDT results
during any prior study visits were dichotomized as
negative (no prior positive RDT result) or positive
(at least one prior RDT positive result) for the
analysis.
In 2008, 99 individuals enrolled in the longitudinal
cohort had at least two study visits. Of these, nine
participants had a single RDT positive result and one
participant had two RDT positive results. In 2009,
168 individuals enrolled in the longitudinal cohort
had at least two study visits. Only two were RDT
positive and none had multiple RDT positive results.
Due to the small number of RDT positive results in
2009, the association between RDT positivity and
antibody levels to P. falciparum antigens was not
examined.
The association between the antibody levels to
P. falciparum antigens and a concurrent or prior
documented episode of malaria was assessed, adjust-
ing for age. In 2007, participants with a positive RDT
result at the concurrent visit had a 0.177 higher OD
value (95% CI: 0.063, 0.292, p = 0.002) than RDT
negative participants, adjusting for age (Table 2). In
2008, participants with a positive RDT result at the
concurrent visit had a statistically non-significant
0.063 lower OD value (95% CI: -0.245, 0.119, p =
0.51) than RDT negative participants after adjusting
for age (Table 2). Participants with at least one posi-
tive RDT result at any prior visit during the study
period had a 0.261 higher OD value (95% CI: 0.090,
0.432, p = 0.003) in 2007 and a 0.116 higher OD
value (95% CI: 0.009, 0.222, p = 0.03) in 2008 com-
pared to RDT negative participants after adjusting
for age (Table 2).Table 2 Association between RDT positivity at the concurrent
and 2008
Coefficient
Positive RDT result at the concurrent study visit 0.177
Positive RDT result at the prior study visit 0.261Spatial clustering of households comprised of individuals
with serologic evidence of recent malaria
The coefficient for the OD value from the linear model
for individuals having at least one positive RDT result at
any prior visit during the study period in 2008 (β = 0.116),
was used to assess whether serology could be used to
identify spatial clusters of malaria transmission in the
study area for 2008 and 2009. In 2008, 55 participants had
samples collected at the beginning (February) and end
(December) of the study period. The median age at the
first study visit was 11 years (IQR: 6, 33) and the median
interval between the first and the last study visit was 296
days (range: 284 to 305 days). Of these 55 participants, 43
(78%) with a median age of 14 years (IQR: 7, 36) had OD
values that increased more than 0.116. In 2009, 74 indivi-
duals had samples collected at the beginning (January)
and end (December) of the study period. The median age
at the first study visit was 13 years (IQR: 5.6, 35) and the
median interval between the first and last study visit was
305 days (range: 281 to 324 days). Of these 74 partici-
pants, 10 (14%) with a median age of 21 years (IQR: 7.4,
30) had an OD values that exceeded 0.116.
Participants with OD values that exceeded 0.116 over
the one year study period were classified as cases and
clusters of households with cases were identified.
The primary household clusters identified in 2008
(within a 9.2 km radius) were not statistically signifi-
cant (p = 0.15), but household clusters identified in 2009
(within a 5.4 km radius) achieved marginal statistical
significance (p = 0.06) (Table 3). Study households were
overlaid on a malaria risk map generated from ecological
characteristics of the terrain [20] to assess whether spatial
clusters of recent malaria cases identified serologically
were consistent with ecological predictors of malaria
transmission in the study area (Figure 3). The cluster
of households identified serologically in 2009 overlapped
a region previously identified to be at risk for malaria
transmission (Figure 3).
Discussion
Antibody levels to whole, asexual stage P. falciparum
antigens measured by enzyme immunoassay increased
with increasing age and were correlated with prior





Table 3 Spatial clusters of households with positive cases more than expected, 2008 and 2009







2008 27 25 21.11 1.44 0.15
2009 34 9 4.59 10.59 0.06
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In the year with the lowest parasite prevalence, spatial
clustering of individuals with serologic evidence of
recent infection overlapped with a region at risk for malaria
transmission as previously determined by ecological factors
[20]. These findings suggest that serology may be a
useful tool for monitoring malaria transmission in
regions of declining malaria burden with low levels of
parasite prevalence.
Residents of malaria endemic areas acquire antibodies
to P. falciparum and clinical immunity to malaria after
repeated exposure, with earlier acquisition of seroposi-
tivity and clinical immunity in regions with higher trans-
mission intensity [25]. Immunity to clinical malaria and
seropositivity increase with increasing age due to cumu-
lative exposure to malaria parasites; however, protective
immunity may wane in the absence of repeated exposure
to malaria parasites [26]. In southern Zambia, antibody
levels demonstrated age-dependent increases consistent
with other studies [10,11]. Although antibodies to whole
parasite lysate were measured, prior reports demon-
strated that antibody responses to whole schizont extractFigure 3 Spatial clusters of recent malaria cases identified serological
households are shown in black (2008) and white (2009) dots. Spatial cluste
recent malaria infection are shown in the large circles (2008 = grey; 2009 =
ecological features of the terrain [20], with the darker red indicating a highwere comparable to antibody responses to single anti-
gens such as AMA1 and MSP-119 [14].
The use of serology as a marker of malaria transmis-
sion intensity and recent exposure to P. falciparum was
recently described [10]. A potential disadvantage of
serology to track changes in malaria transmission is that
antibody responses to P. falciparum may not be suitable
to detect short term changes in population immunity in
regions with rapid declines in malaria transmission.
This study attempted to identify recent exposure to P.
falciparum by measuring an increase in OD values above
the expected value for having RDT positive result during
one year study period. The findings suggest that recent
exposure to P. falciparum can be detected through
increases in OD values. Prior studies measured antibody
responses to single parasite antigens, such as AMA1 or
MSP119, and samples were collected in cross-sectional
studies [9,11-13]. In contrast, we were able to measure
serological responses in a longitudinal cohort and adjusted
for within-individual heterogeneity.
Spatial clusters of individuals with serological evidence
of recent infection was identified and these clusters werely and ecological predictors of malaria transmission. Study
rs of households comprising residents with serologic evidence of
light grey). The background consists of a malaria risk map based on
er risk of malaria.
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malaria risk map of the study area [20]. Prior studies
identified clusters of malaria transmission using serology
but the reported clusters were smaller (< 1 km) than the
clusters identified in southern Zambia (> 5 km) [27,28].
The small sizes of the clusters were attributed to the
estimated distance traversed by the mosquito vector
[29]. In these studies, antibodies to specific antigens
such as MSP119, AMA1 and MSP2 were measured; the
broader antibody response to whole parasite lysate in
our study may account for the larger cluster sizes.
Conclusions
Antibodies to whole, asexual stage P. falciparum antigens
were positively correlated with prior RDT positivity. Sero-
logical surveys to whole asexual P. falciparum antigens
using blood collected as dried blood spots can be
used to detect recent malaria infection and identify
focal areas of transmission, particularly in a region of
declining malaria burden.
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